Risk aversion, small-cap slump hit SME IPOs as collections drop 73%

CY18 was the best for SME IPOs, with 141 offerings garnering Rs 2,287 crore

IPOs, funding
Ashley Coutinho Mumbai
3 min read Last Updated : Jan 01 2020 | 2:07 AM IST
Collections from public share sales of small and medium enterprises (SMEs) in 2019 have dropped 73 per cent over the previous year to Rs 617 crore, given that risk aversion among investors and the fall in mid- and small-cap stocks have hit investor sentiment.

The number of listings reduced by a third in 2019, over the previous calendar year (CY). This was the first time in five years that the mop-up from such share sales slid, even as the amount collected in 2019 was higher than in 2013, 2014, 2015, and 2016. 

CY18 was the best for SME IPOs, with 141 offerings garnering Rs 2,287 crore.

“The decline in the number of SME IPOs is in line with the overall primary market sentiment and risk aversion among investors after the steep correction in mid- and small-cap stocks,” said Mahavir Lunawat, chairman and managing director, Pantomath Advisory Services Group, which is active in the SME space.

Despite this, Lunawat said, the SME segment has witnessed more activities than the mainboard in terms of number of IPOs. “There is a healthy pipeline of companies waiting to hit the market and the mop-up from SME IPOs is expected to improve in the next financial year,” he said.

The performance of companies listed this year has been a mixed bag: 24 companies are in the green, with five gaining more than 100 per cent; 21 firms are trading in the red, with seven companies shedding more than 50 per cent. Average returns of these companies stood at 21.5 per cent, compared to -6.8 per cent for the BSE SmallCap index.


Sectors, such as trading & distribution, retail and textiles, dominated the SME capital market this year, according to Pantomath. “Price performance of SMEs listed in CY19 have been disappointing, resulting in a decline in market valuations,” it said.

Despite the possibility of high returns, experts said there was a high probability of losing one’s entire capital in SME stocks. Analysing these firms can be a challenge as they are neither tracked by analysts nor there is much information in the public domain. 

“Investors have to a lot more selective in the SME space and carefully study the business model a company operates before investing,” said the research head of a mid-size capital market firm.
 
The SME segment has been grappling with issues, such as lack of liquidity and lacklustre institutional participation. According to experts, the need is to bring in priority investing from big institutional players and tweak the lot size to improve liquidity.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IPOsSME IPOsSMEs

Next Story